These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9531690)

  • 1. [Autoantibodies in chronic inflammatory bowel diseases: more than an epiphenomenon?].
    Folwaczny C; Fricke H
    Z Gastroenterol; 1998 Jan; 36(1):105-8. PubMed ID: 9531690
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibodies to neutrophilic granulocytes (p-ANCA): a further indication for a common origin of ulcerative colitis and primary sclerosing cholangitis?].
    Jahn HU; Zeitz M
    Z Gastroenterol; 1992 Jun; 30(6):441-2. PubMed ID: 1636280
    [No Abstract]   [Full Text] [Related]  

  • 3. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.
    Seibold F; Slametschka D; Gregor M; Weber P
    Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases.
    Claise C; Johanet C; Bouhnik Y; Kapel N; Homberg JC; Poupon R
    Liver; 1996 Feb; 16(1):28-34. PubMed ID: 8868075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enigma of anti-neutrophil antibodies in ulcerative colitis primary sclerosing cholangitis: important genetic marker or epiphenomenon?
    Chapman RW
    Hepatology; 1995 May; 21(5):1473-4. PubMed ID: 7737656
    [No Abstract]   [Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases.
    Tervaert JW; Mulder AH; Horst G; Haagsma EB; Kleibeuker JH; Kallenberg CG
    Gastroenterology; 1992 Mar; 102(3):1090-1. PubMed ID: 1537508
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoimmune hepatitis in inflammatory bowel disease: report of two unusual cases.
    Seibold F; Weber P; Jenss H; Scheurlen M
    Z Gastroenterol; 1997 Jan; 35(1):29-32. PubMed ID: 9123955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology of inflammatory bowel disease--an update.
    Jewell DP
    J Gastroenterol; 1995 Nov; 30 Suppl 8():78-82. PubMed ID: 8563898
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
    Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH
    Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune reactivity in inflammatory bowel disease.
    Keren DF; Goeken JA
    Clin Lab Med; 1997 Sep; 17(3):465-81. PubMed ID: 9316769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANCA in IBD: nice, but necessary?
    Heiman DR; DiPalma JA
    Am J Gastroenterol; 1995 Nov; 90(11):2066-7. PubMed ID: 7485033
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bactericidal permeability increasing protein (BPI-ANCA marked chronic inflammatory bowel diseases and hepatobiliary diseases].
    Schnabel A; Csernok E; Schultz H; Stoffel M; Herzberg C; Carroll SF; Gross WL
    Med Klin (Munich); 1997 Jul; 92(7):389-93. PubMed ID: 9324622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineutrophil and pancreatic autoantibodies in first-degree relatives of patients with inflammatory bowel disease.
    Folwaczny C; Noehl N; Endres SP; Loeschke K; Fricke H
    Scand J Gastroenterol; 1998 May; 33(5):523-8. PubMed ID: 9648993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease.
    Hartman C; Eliakim R; Shamir R
    Isr Med Assoc J; 2004 Apr; 6(4):221-6. PubMed ID: 15115261
    [No Abstract]   [Full Text] [Related]  

  • 15. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases.
    Zauli D; Baffoni L; Cassani F; Fusconi M; Lenzi M; Ballardini G; Luigi M; Bianchi FB; Schrumpf E
    Gastroenterology; 1992 Mar; 102(3):1088-90. PubMed ID: 1537507
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic inflammatory bowel diseases: immunologic changes--cause or epiphenomenon?].
    Zeitz M
    Z Gastroenterol Verh; 1989 Jul; 24():26-30. PubMed ID: 2474975
    [No Abstract]   [Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic antibodies in Turkish children with inflammatory bowel disease.
    Gürakan F; Koçak N; Ozen H; Yüce A
    Am J Gastroenterol; 2000 Apr; 95(4):1095. PubMed ID: 10763976
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-neutrophil cytoplasmic auto-antibodies (ANCA) in patients with ulcerative colitis (UC): influence of disease activity and familial study.
    Reumaux D; Colombel JF; Delecourt L; Noël LH; Cortot A; Duthilleul P
    Adv Exp Med Biol; 1993; 336():515-8. PubMed ID: 8296667
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases.
    Ardesjö B; Hansson CM; Bruder CE; Rorsman F; Betterle C; Dumanski JP; Kämpe O; Ekwall O
    J Autoimmun; 2008 Jun; 30(4):273-82. PubMed ID: 18242955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of primary sclerosing cholangitis with inflammatory bowel diseases: a prospective study.
    Purrmann J; Mödder U; Cleveland S; Seibold F; Burchard A; Gemsa R; Lübke H
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():56-9. PubMed ID: 8197804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.